Skip to main content

Table 2 List of adverse effects

From: Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Patient No

Treatment

Adverse event

System organ class

Adverse effect intensity

Relationship to investigational medicinal product

TR10006

Active

Pruritus

Skin and subcutaneous tissue disorders

Mild

Unrelated

TR10011

Active

Dizziness

Nervous system disorders

Mild

Unrelated

TR10034

Active

Diarrhea

Gastrointestinal disorders

Moderate

Unrelated

TR10036

Active

Diarrhea

Gastrointestinal disorders

Moderate

Unrelated

TR20045

Active

Nausea

Gastrointestinal disorders

Moderate

Unknown